1. Home
  2. RLMD vs HUSA Comparison

RLMD vs HUSA Comparison

Compare RLMD & HUSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RLMD
  • HUSA
  • Stock Information
  • Founded
  • RLMD 2004
  • HUSA N/A
  • Country
  • RLMD United States
  • HUSA United States
  • Employees
  • RLMD N/A
  • HUSA N/A
  • Industry
  • RLMD Biotechnology: Pharmaceutical Preparations
  • HUSA Oil & Gas Production
  • Sector
  • RLMD Health Care
  • HUSA Energy
  • Exchange
  • RLMD Nasdaq
  • HUSA Nasdaq
  • Market Cap
  • RLMD 20.3M
  • HUSA 21.3M
  • IPO Year
  • RLMD N/A
  • HUSA N/A
  • Fundamental
  • Price
  • RLMD $0.59
  • HUSA $9.64
  • Analyst Decision
  • RLMD Buy
  • HUSA
  • Analyst Count
  • RLMD 3
  • HUSA 0
  • Target Price
  • RLMD $5.00
  • HUSA N/A
  • AVG Volume (30 Days)
  • RLMD 206.5K
  • HUSA 257.0K
  • Earning Date
  • RLMD 08-07-2025
  • HUSA 08-13-2025
  • Dividend Yield
  • RLMD N/A
  • HUSA N/A
  • EPS Growth
  • RLMD N/A
  • HUSA N/A
  • EPS
  • RLMD N/A
  • HUSA N/A
  • Revenue
  • RLMD N/A
  • HUSA N/A
  • Revenue This Year
  • RLMD N/A
  • HUSA N/A
  • Revenue Next Year
  • RLMD N/A
  • HUSA N/A
  • P/E Ratio
  • RLMD N/A
  • HUSA N/A
  • Revenue Growth
  • RLMD N/A
  • HUSA N/A
  • 52 Week Low
  • RLMD $0.24
  • HUSA $3.85
  • 52 Week High
  • RLMD $3.98
  • HUSA $32.00
  • Technical
  • Relative Strength Index (RSI)
  • RLMD 44.70
  • HUSA 46.11
  • Support Level
  • RLMD $0.60
  • HUSA $10.50
  • Resistance Level
  • RLMD $0.67
  • HUSA $11.85
  • Average True Range (ATR)
  • RLMD 0.06
  • HUSA 0.90
  • MACD
  • RLMD -0.00
  • HUSA -0.20
  • Stochastic Oscillator
  • RLMD 16.42
  • HUSA 24.04

About RLMD Relmada Therapeutics Inc.

Relmada Therapeutics Inc is a clinical-stage biotechnology company. It is engaged in developing chemical entities with novel versions of drug products that address areas of high unmet medical need in the treatment of central nervous system diseases. The company is focused on the development of esmethadone (d-methadone, dextromethadone, REL-1017), an N-methyl-D-aspartate (NMDA) receptor antagonist. Its key product candidate, esmethadone, is an oral agent for the treatment of depression and other potential indications.

About HUSA Houston American Energy Corporation

Houston American Energy Corp is an independent oil and gas company focused on the development, exploration, exploitation, acquisition, and production of natural gas and crude oil properties. Its properties, and operations, are in the U.S. Permian Basin, the U.S. Gulf Coast region, particularly Louisiana, and the South American country of Colombia. Geographically, the company currently has operations in two geographical areas, the United States, from where it derives maximum revenue, and Colombia.

Share on Social Networks: